4//SEC Filing
Parison Amy 4
Accession 0001650664-25-000052
CIK 0001650664other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:29 PM ET
Size
5.4 KB
Accession
0001650664-25-000052
Insider Transaction Report
Form 4
Parison Amy
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-08+34,672→ 34,672 totalExercise: $0.98Exp: 2035-04-07→ Common Stock (34,672 underlying)
Footnotes (1)
- [F1]This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly monthly installments thereafter through April 8, 2029.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0002063082
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:29 PM ET
- Size
- 5.4 KB